Moreover, these cross models and disc tissues’ common transcripts fortify previous NP and AF gene signature analysis, suggesting JUN signaling as a critical convergence point conferring the benefits of the systemic DQ treatment on disc health. This evidence concerns the gene JUN and atrial fibrillation.